Literature DB >> 33584675

Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2?

Anastasia Polycarpou1, Sofia Grigoriadou2, Linda Klavinskis1, Steven Sacks1.   

Abstract

Entities:  

Keywords:  COVID-19; Kawasaki disease; SARS-CoV-2; children; complement; lectin pathway; multisystem inflammatory syndrome; paediatric

Year:  2021        PMID： 33584675      PMCID： PMC7874141          DOI： 10.3389/fimmu.2020.604512

Source DB:  PubMed          Journal:  Front Immunol        ISSN： 1664-3224            Impact factor:   7.561


× No keyword cloud information.
  32 in total

Review 1.  Lectin Complement Pathway and Its Bloody Interactions in Brain Ischemia.

Authors:  Stefano Fumagalli; Maria-Grazia De Simoni
Journal:  Stroke       Date:  2016-11-03       Impact factor: 7.914

2.  A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms.

Authors:  Yanchen Zhou; Kai Lu; Susanne Pfefferle; Stephanie Bertram; Ilona Glowacka; Christian Drosten; Stefan Pöhlmann; Graham Simmons
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

Review 3.  A journey through the lectin pathway of complement-MBL and beyond.

Authors:  Peter Garred; Ninette Genster; Katrine Pilely; Rafael Bayarri-Olmos; Anne Rosbjerg; Ying Jie Ma; Mikkel-Ole Skjoedt
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

4.  Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin.

Authors:  Katy J Fidler; Peter Wilson; Jane C Davies; Malcolm W Turner; Mark J Peters; Nigel J Klein
Journal:  Intensive Care Med       Date:  2004-05-04       Impact factor: 17.440

5.  Plasma MASP-1 concentration and its relationship to recovery from coronary artery lesion in children with Kawasaki disease.

Authors:  Rui-Xia Song; Qing-Mei Zou; Xiao-Hui Li; Nan-Ping Xu; Ting Zhang; Jin Fu; Xiao-Dai Cui
Journal:  Pediatr Res       Date:  2015-11-04       Impact factor: 3.756

6.  Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature.

Authors:  David Kavanagh; Sarah McGlasson; Alexa Jury; Jac Williams; Neil Scolding; Chris Bellamy; Claudia Gunther; Diane Ritchie; Daniel P Gale; Yashpal S Kanwar; Rachel Challis; Holly Buist; James Overell; Belinda Weller; Oliver Flossmann; Mark Blunden; Eric P Meyer; Thomas Krucker; Stephen J W Evans; Iain L Campbell; Andrew P Jackson; Siddharthan Chandran; David P J Hunt
Journal:  Blood       Date:  2016-09-23       Impact factor: 25.476

7.  Hyperinflammatory shock in children during COVID-19 pandemic.

Authors:  Shelley Riphagen; Xabier Gomez; Carmen Gonzalez-Martinez; Nick Wilkinson; Paraskevi Theocharis
Journal:  Lancet       Date:  2020-05-07       Impact factor: 79.321

8.  The transcriptional profile of coronary arteritis in Kawasaki disease.

Authors:  Anne H Rowley; Kristine M Wylie; Kwang-Youn A Kim; Adam J Pink; Amy Yang; Rebecca Reindel; Susan C Baker; Stanford T Shulman; Jan M Orenstein; Mark W Lingen; George M Weinstock; Todd N Wylie
Journal:  BMC Genomics       Date:  2015-12-18       Impact factor: 3.969

9.  FCN1 (M-ficolin), which directly associates with immunoglobulin G1, is a molecular target of intravenous immunoglobulin therapy for Kawasaki disease.

Authors:  Daisuke Okuzaki; Kaori Ota; Shin-Ichi Takatsuki; Yukari Akiyoshi; Kazuyuki Naoi; Norikazu Yabuta; Tsutomu Saji; Hiroshi Nojima
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

10.  An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.

Authors:  Lucio Verdoni; Angelo Mazza; Annalisa Gervasoni; Laura Martelli; Maurizio Ruggeri; Matteo Ciuffreda; Ezio Bonanomi; Lorenzo D'Antiga
Journal:  Lancet       Date:  2020-05-13       Impact factor: 79.321
View more
  3 in total

Review 1.  Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C.

Authors:  Manpreet Dhaliwal; Rahul Tyagi; Pooja Malhotra; Prabal Barman; Sathish Kumar Loganathan; Jyoti Sharma; Kaushal Sharma; Sanjib Mondal; Amit Rawat; Surjit Singh
Journal:  Front Pediatr       Date:  2022-05-05       Impact factor: 3.569

2.  The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery.

Authors:  Eleni Syrimi; Eanna Fennell; Alex Richter; Pavle Vrljicak; Richard Stark; Sascha Ott; Paul G Murray; Eslam Al-Abadi; Ashish Chikermane; Pamela Dawson; Scott Hackett; Deepthi Jyothish; Hari Krishnan Kanthimathinathan; Sean Monaghan; Prasad Nagakumar; Barnaby R Scholefield; Steven Welch; Naeem Khan; Sian Faustini; Kate Davies; Wioleta M Zelek; Pamela Kearns; Graham S Taylor
Journal:  iScience       Date:  2021-10-02

Review 3.  Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.

Authors:  Chetan Sharma; Madhusudan Ganigara; Caroline Galeotti; Joseph Burns; Fernando M Berganza; Denise A Hayes; Davinder Singh-Grewal; Suman Bharath; Sujata Sajjan; Jagadeesh Bayry
Journal:  Nat Rev Rheumatol       Date:  2021-10-29       Impact factor: 20.543
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.